Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

New Zealand (NZX) Healthcare Sector Analysis

UpdatedJun 05, 2026
DataAggregated Company Financials
Companies14
  • 7D-1.4%
  • 3M-8.6%
  • 1Y-11.5%
  • YTD-10.7%

Over the last 7 days, the Healthcare industry has dropped 1.5%, driven by Fisher & Paykel Healthcare declining 2.5%. The industry has fallen 11% in the last year. Earnings are forecast to grow by 22% annually.

Sector Valuation and Performance

Has the New Zealand Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 05 Jun 2026NZ$31.5bNZ$20.2bNZ$829.4m16.8x38x1.6x
Sun, 03 May 2026NZ$31.2bNZ$20.0bNZ$453.2m18.3x68.8x1.6x
Tue, 31 Mar 2026NZ$31.2bNZ$19.8bNZ$448.0m18.1x69.7x1.6x
Thu, 26 Feb 2026NZ$34.9bNZ$19.6bNZ$557.8m18.2x62.5x1.8x
Sat, 24 Jan 2026NZ$35.5bNZ$18.3bNZ$534.8m19.9x66.4x1.9x
Mon, 22 Dec 2025NZ$34.7bNZ$18.2bNZ$532.1m21.2x65.1x1.9x
Wed, 19 Nov 2025NZ$34.8bNZ$17.9bNZ$571.9m22.9x60.8x1.9x
Fri, 17 Oct 2025NZ$34.2bNZ$17.8bNZ$574.4m19.8x59.6x1.9x
Sun, 14 Sep 2025NZ$34.6bNZ$17.6bNZ$570.5m17.8x60.6x2x
Tue, 12 Aug 2025NZ$36.2bNZ$17.7bNZ$572.4m18.7x63.2x2x
Thu, 10 Jul 2025NZ$36.1bNZ$17.5bNZ$570.2m17.9x63.3x2.1x
Sat, 07 Jun 2025NZ$35.0bNZ$17.4bNZ$567.2m14.8x61.7x2x
Mon, 05 May 2025NZ$34.2bNZ$17.3bNZ$655.4m16.1x52.2x2x
Wed, 02 Apr 2025NZ$34.1bNZ$17.5bNZ$659.6m16.9x51.8x1.9x
Fri, 28 Feb 2025NZ$33.8bNZ$17.6bNZ$706.5m16.4x47.8x1.9x
Sun, 26 Jan 2025NZ$36.8bNZ$18.2bNZ$734.3m14.7x50.2x2x
Tue, 24 Dec 2024NZ$36.8bNZ$18.2bNZ$728.7m12.4x50.5x2x
Thu, 21 Nov 2024NZ$38.1bNZ$18.3bNZ$942.3m17.6x40.5x2.1x
Sat, 19 Oct 2024NZ$37.4bNZ$18.3bNZ$967.9m20.1x38.7x2.1x
Mon, 16 Sep 2024NZ$38.0bNZ$18.0bNZ$963.5m20.4x39.4x2.1x
Wed, 14 Aug 2024NZ$34.1bNZ$17.5bNZ$972.9m19.6x35x1.9x
Fri, 12 Jul 2024NZ$31.5bNZ$17.7bNZ$977.4m16.5x32.3x1.8x
Sun, 09 Jun 2024NZ$30.5bNZ$17.3bNZ$960.3m17.2x31.8x1.8x
Tue, 07 May 2024NZ$30.6bNZ$17.5bNZ$1.3b24.2x23.8x1.8x
Thu, 04 Apr 2024NZ$29.2bNZ$17.3bNZ$1.3b23.9x22.7x1.7x
Sat, 02 Mar 2024NZ$28.8bNZ$17.0bNZ$1.3b18.5x22.2x1.7x
Mon, 29 Jan 2024NZ$29.4bNZ$16.7bNZ$1.1b20.5x26x1.8x
Wed, 27 Dec 2023NZ$28.8bNZ$16.7bNZ$1.1b23.4x25.5x1.7x
Fri, 24 Nov 2023NZ$27.5bNZ$16.5bNZ$1.1b24.7x24.8x1.7x
Sun, 22 Oct 2023NZ$26.8bNZ$16.5bNZ$1.1b31x24.2x1.6x
Tue, 19 Sep 2023NZ$28.3bNZ$16.6bNZ$1.1b29.2x25.5x1.7x
Thu, 17 Aug 2023NZ$29.4bNZ$15.8bNZ$1.1b29.3x27.3x1.9x
Sat, 15 Jul 2023NZ$30.9bNZ$15.7bNZ$1.1b30.1x28.8x2x
Mon, 12 Jun 2023NZ$29.1bNZ$16.0bNZ$1.1b30x27x1.8x
Price to Earnings Ratio

27x


Total Market Cap: NZ$29.1bTotal Earnings: NZ$1.1bTotal Revenue: NZ$16.0bTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Healthcare Sector Price to Earnings3Y Average 44.4x202420252026
Current Industry PE
  • Investors are pessimistic on the New Zealander Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 37.9x which is lower than its 3-year average PE of 44.4x.
  • The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.6x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 8.4% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the New Zealand Healthcare sector?

NZ Market-0.35%
Healthcare-1.36%
Biotech5.66%
Healthcare Services1.04%
Pharma0.81%
Medical Equipment-2.47%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 81.7x.
    • Analysts are expecting annual earnings growth of 13.3%, which is lower than the prior year's growth of 24.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 65% over the next 5 years.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EBO EBOS GroupNZ$20.113.0%
+NZ$122.1m		-46.6%PE14.9x
PEB Pacific EdgeNZ$0.307.1%
+NZ$23.4m		209.3%PS27x
SUM Summerset Group HoldingsNZ$8.060.5%
+NZ$9.7m		-27.1%PE7.6x
PHL Promisia HealthcareNZ$0.683.0%
+NZ$1.1m		81.3%PE2.8x
TRU TruScreen GroupNZ$0.0195.6%
+NZ$747.3k		-20.8%PS5x

Latest News

RYM
NZ$2.25
Ryman Healthcare
7D
-0.4%
1Y
-0.9%
TRU
NZ$0.019
TruScreen Group
7D
5.6%
1Y
-20.8%
PHL
NZ$0.68
Promisia Healthcare
7D
3.0%
1Y
81.3%
Analysis Article • 19h

We Think That There Are Issues Underlying Promisia Healthcare's (NZSE:PHL) Earnings

Promisia Healthcare Limited's ( NZSE:PHL ) stock was strong after they recently reported robust earnings. However, we...
TAH
NZ$4.76
Third Age Health Services
7D
-0.8%
1Y
34.1%
OCA
NZ$0.76
Oceania Healthcare
7D
-2.6%
1Y
25.8%
FPH
NZ$37.18
Fisher & Paykel Healthcare
7D
-0.3%
1Y
1.9%
Narrative Update • Jun 02

FPH: Strong Earnings And Higher Dividend Will Support Balanced Future Repricing

Analysts have trimmed their price target on Fisher & Paykel Healthcare from NZ$40.59 to NZ$39.63, citing updated assumptions for revenue growth, profit margins, and future P/E multiples. What's in the News Fisher & Paykel Healthcare reported a 14% gain in operating revenue for the 2026 financial year, according to its full year 2026 earnings call highlights.
PEB
NZ$0.30
Pacific Edge
7D
7.1%
1Y
209.3%
AFT
NZ$3.91
AFT Pharmaceuticals
7D
-0.5%
1Y
41.7%
Analysis Article • May 29

AFT Pharmaceuticals' (NZSE:AFT) Profits Appear To Have Quality Issues

Following the solid earnings report from AFT Pharmaceuticals Limited ( NZSE:AFT ), the market responded by bidding up...
RAD
NZ$0.39
Radius Residential Care
7D
-3.8%
1Y
32.8%
BLT
NZ$0.016
BLIS Technologies
7D
-5.9%
1Y
0%
EBO
NZ$20.11
EBOS Group
7D
3.0%
1Y
-46.6%
Narrative Update • May 19

EBO: Index Removal And Discount Rate Shift Will Support Capital Efficiency Reassessment

Analysts now cite a slightly lower fair value estimate for EBOS Group, trimming the indicative price target from around NZ$33.63 to NZ$33.31 as modest adjustments to the discount rate, profit margin and assumed future P/E feed through their models. What's in the News EBOS Group Limited (ASX:EBO) was removed from the S&P/ASX 200 Index.
SUM
NZ$8.06
Summerset Group Holdings
7D
0.5%
1Y
-27.1%
MEE
NZ$0.049
Me Today
7D
-9.3%
1Y
-14.0%